CN102641290A - External medicinal powder for treating bedsore - Google Patents
External medicinal powder for treating bedsore Download PDFInfo
- Publication number
- CN102641290A CN102641290A CN2012101093767A CN201210109376A CN102641290A CN 102641290 A CN102641290 A CN 102641290A CN 2012101093767 A CN2012101093767 A CN 2012101093767A CN 201210109376 A CN201210109376 A CN 201210109376A CN 102641290 A CN102641290 A CN 102641290A
- Authority
- CN
- China
- Prior art keywords
- parts
- bedsore
- medicinal powder
- treating
- external medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses external medicinal powder for treating bedsore, which belongs to the technical field of traditional Chinese medicine compositions. The external medicinal powder for treating the bedsore is formed by combining processed calamine, talcum, cinnabar, borneol, gypsum, stalactite and calcite according to a certain mixture ratio so as to form a mutually complementary and beneficial effect, so that the external medicinal powder for treating the bedsore has the effects of clearing away heat and toxic materials, converging and alleviating pain. Therefore, the bedsore can be effectively treated, the treatment course is short, the curative effect is obvious, and any toxic or side effect does not exist. According to statistics in the observation of 100 patients clinically, the effective rate of using the medicine disclosed by the invention for one treatment course is 96 percent, and the effective rate of using the medicine disclosed by the invention for two treatment courses is 99 percent.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, especially a kind of external pulvis of treating decubital ulcer.
Background technology
Decubital ulcer has another name called bed-sore, mainly because of long-term bed does not rise, and the prolonged illness deficiency of both QI and blood; Lose in circulation because of pressurized position QI and blood again; Can not the nutrition skin, thus cause local necrosis, fester, suppurate water even the mashed bone of rotten muscle, primary disease is common in stupor, hemiplegia difficulty surgical disease; Treatment is also more thorny clinically, and domestic some Chinese and western medicine preparation curative effect when the treatment decubital ulcer is undesirable.Some Chinese medicine external-applied ointment can only impel skin ulcer face length muscle during application, but is difficult to impel the wound surface skin to close up.When particularly some older patients merged decubital ulcer, the generation that the decubital ulcer obstinate aggravates disease caused not controlling eventually.The between twenty and fifty decubital ulcer of suffering from causes seeking medical advice in hospital for a long time, increases the weight of the financial burden of patient's thought.
Summary of the invention
Main task of the present invention provides a kind of external pulvis of treating decubital ulcer, and this external pulvis has heat-clearing and toxic substances removing, convergence analgesic effect.
The present invention selects Calamina(processed), Talcum, Cinnabaris, Borneolum Syntheticum, Gypsum Fibrosum, Stalactitum and Mirabilitum crystallina to make up; Make each efficacy of drugs produce synergism these drug regimens; Make it to have heat-clearing and toxic substances removing, restrain the analgesic effect, thereby can effectively treat decubital ulcer.
Wherein, Calamina(processed): be the Ore of carbonate mineral smithsonite.Nature and flavor are sweet, and are flat, return the stomach warp.Have the antipruritic effect of holding back skin ulcer of removing dampness, be used for ulcer being unable to heal, pus is dripping, eczema, symptoms such as skin pruritus.External can suppress local aureus growth, can partially absorb the wound surface juice, and convergence, protective effect are arranged.
Talcum: be silicates mineral talc family Talcum.Nature and flavor are sweet, light, and are cold.Return bladder, lung, stomach warp.Has the effect that skin ulcer is held back in damp eliminating.The outer time spent, spreading can form the protectiveness film when inflammation or damaged organize surperficial, both can reduce local friction, prevents external irritant, also can absorb a large amount of chemical irritants or poisonous substance. and the absorption juice is arranged, promote dry, incrustation effect.
Cinnabaris: be sulfide-based mineral cinnabar family cinnabar.Nature and flavor are sweet, are slightly cold.Slightly poisonous.The GUIXIN warp.Effect with heat-clearing and toxic substances removing, external can suppress or kill skin bacterium and parasite.
Borneolum Syntheticum: being the crystallization that from the resin of Borneolum Syntheticum and volatile oil, obtains, is to be close to pure dextro Borneolum Syntheticum.Nature and flavor are arduous, cold.Go into the heart, lung meridian.Have diffusing stagnated fire, the effect of reducing swelling and alleviating pain has better curative effect to some ulcer property or erosive scytitis, and analgesic effect is obvious, quickens inflammation and eliminates, and promotes erosion and ulcer healing.
Gypsum Fibrosum: be the monoclinic system mineral, main chemical compositions is calcium sulfate (CaSO4).Nature and flavor are cold, and are lightly seasoned, go into lung, stomach warp.Have heat-clearing and toxic substances removing, the effect of promoting tissue regeneration and ulcer healing can suppress the breeding development of pathogenic microorganism.
Stalactitum: be carbonate mineral calcite family calcite, main carbonated calcium (CaCO3).Nature and flavor are sweet, temperature.Return lung, kidney, stomach warp.Have and control deficiently, clear and coherent blood vessels, the utmost point are mended the effect of the therapeutic method to keep the adverse QI flowing downwards.
Mirabilitum crystallina: for being rich in the mineral crystal of Sulfates mineral.Nature and flavor are hot, salty, and are cold.GUIXIN, stomach, kidney channel.Have resolving heat and reducing pathogenic fire, the effect of skin ulcer is held back in detumescence.
Medicine material consumption of the present invention is groped to sum up to draw through the inventor in a large number, and each raw material consumption is for all to have curative effect preferably in the following weight parts scope: 10-30 parts of Calamina(processed), 20-40 parts in Talcum, 5-15 parts in Cinnabaris, 8-18 parts of Borneolum Syntheticums, 20-40 parts in Gypsum Fibrosum, 10-20 parts of Stalactitums, 10-20 parts of Mirabilitum crystallinas.
Wherein be preferably: 20 parts of Calamina(processed), 30 parts in Talcum, 9 parts in Cinnabaris, 12 parts of Borneolum Syntheticums, 30 parts in Gypsum Fibrosum, 15 parts of Stalactitums, 15 parts of Mirabilitum crystallinas.
Medicine of the present invention adopts the conventional method preparation of Chinese powder medicine: with sieving behind these crude drug pulverizes, mix homogeneously is processed powder.
Medicine of the present invention has the effect of heat-clearing and toxic substances removing, convergence pain relieving, and short treating period is evident in efficacy, without any side effects, according to clinical 100 routine patients are observed statistics, use a medicine effective percentage course of treatment of the present invention be 96%, two the course of treatment effective percentage be 99%.
The specific embodiment
Embodiment one, 10 parts of Calamina(processed), 20 parts in Talcum, 5 parts in Cinnabaris, 8 parts of Borneolum Syntheticums, 20 parts in Gypsum Fibrosum, 10 parts of Stalactitums, 10 parts of Mirabilitum crystallinas.
Embodiment two, 20 parts of Calamina(processed), 30 parts in Talcum, 9 parts in Cinnabaris, 12 parts of Borneolum Syntheticums, 30 parts in Gypsum Fibrosum, 15 parts of Stalactitums, 15 parts of Mirabilitum crystallinas.
Embodiment three, 30 parts of Calamina(processed), 40 parts in Talcum, 15 parts in Cinnabaris, 18 parts of Borneolum Syntheticums, 40 parts in Gypsum Fibrosum, 20 parts of Stalactitums, 20 parts of Mirabilitum crystallinas.
Be the clinical statistics data that the patient uses medicine of the present invention below:
One, physical data
Collect in January, 2007 to the 2011 year December decubital ulcer patient of my institute totally 100 examples, male's 58 examples, women's 42 examples, 25~78 years old age.
Two, diagnostic criteria
1, tcm diagnosis standard
Stagnation of QI-blood, blood vessels are obstructed, and failure of skin and muscle to be nourished is palor or red then, mild swelling, or color is purple dark, ulceration, unable, the poor appetite of asthenia universalis.Pale tongue, tongue is white, deep-thready pulse.
2, Western medicine diagnose standard
After local compression was compeled, it is pale, greyish white or red that skin just becomes, clear border, and the center color is darker, and patient's condition is carried out rapidly, and vesicle, broken back formation ulcer can take place in the surface.
Three, Therapeutic Method
With embodiment two is example, grinds above-mentioned each crude drug respectively and sieves, and gets fine powder, takes by weighing the fine powder of above-mentioned each crude drug then according to proportioning, and fully mix homogeneously gets external pulvis of the present invention.
Before the medicine-feeding,, the above-mentioned medicated powder for preparing is coated with is sprinkled upon on the wound again, wrap up with antiseptic gauze at last, once a day, a course of treatment Monday, must guarantee affected part drying, health on every side after changing dressings earlier with normal saline flushing affected part pus and slough.
Four, efficacy assessment standard
1, recovery from illness: wound healing, form a scab and come off.
2, produce effects; Wound surface dwindles, no secretions, granulation tissue growth.
3, take a turn for the better: wound fluid reduces, and wound surface does not have expansion.
4, invalid: wound surface enlarges.
Five, therapeutic outcome statistics
Wherein: effective percentage=cure rate+obvious effective rate+improvement rate
Claims (2)
1. an external pulvis of treating decubital ulcer is characterized in that it is to be processed by following bulk drugs: 10-30 parts of Calamina(processed), 20-40 parts in Talcum, 5-15 parts in Cinnabaris, 8-18 parts of Borneolum Syntheticums, 20-40 parts in Gypsum Fibrosum, 10-20 parts of Stalactitums, 10-20 parts of Mirabilitum crystallinas.
2. the external pulvis of treatment decubital ulcer according to claim 1 is characterized in that it is to be processed by following bulk drugs: 20 parts of Calamina(processed), 30 parts in Talcum, 9 parts in Cinnabaris, 12 parts of Borneolum Syntheticums, 30 parts in Gypsum Fibrosum, 15 parts of Stalactitums, 15 parts of Mirabilitum crystallinas.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101093767A CN102641290A (en) | 2012-04-16 | 2012-04-16 | External medicinal powder for treating bedsore |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101093767A CN102641290A (en) | 2012-04-16 | 2012-04-16 | External medicinal powder for treating bedsore |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102641290A true CN102641290A (en) | 2012-08-22 |
Family
ID=46654536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101093767A Pending CN102641290A (en) | 2012-04-16 | 2012-04-16 | External medicinal powder for treating bedsore |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102641290A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103202876A (en) * | 2013-03-04 | 2013-07-17 | 余金标 | Prickly heat powder |
CN106420821A (en) * | 2016-12-15 | 2017-02-22 | 镇平县尤普实业有限公司 | Colla corii asini bedsore nursing powder |
CN109908174A (en) * | 2019-04-10 | 2019-06-21 | 上海市第四人民医院 | A kind of hemorrhoid section Shengji San |
CN114159383A (en) * | 2022-01-12 | 2022-03-11 | 王小平 | External traditional Chinese medicine for treating chronic refractory wound and preparation method thereof |
-
2012
- 2012-04-16 CN CN2012101093767A patent/CN102641290A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103202876A (en) * | 2013-03-04 | 2013-07-17 | 余金标 | Prickly heat powder |
CN103202876B (en) * | 2013-03-04 | 2015-04-22 | 余金标 | Prickly heat powder |
CN106420821A (en) * | 2016-12-15 | 2017-02-22 | 镇平县尤普实业有限公司 | Colla corii asini bedsore nursing powder |
CN109908174A (en) * | 2019-04-10 | 2019-06-21 | 上海市第四人民医院 | A kind of hemorrhoid section Shengji San |
CN114159383A (en) * | 2022-01-12 | 2022-03-11 | 王小平 | External traditional Chinese medicine for treating chronic refractory wound and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105477595A (en) | Traditional Chinese medicinal preparation for treating chilblain | |
CN102641290A (en) | External medicinal powder for treating bedsore | |
CN101352505A (en) | Bone fracture setting medicine powder for treating traumatic injury | |
CN106902252A (en) | It is a kind of for treating bedsore, canker sore, hemorrhoid and the Chinese medicine preparation of anal fissure | |
CN104667035A (en) | Medicament for treating gout | |
CN103877462A (en) | External liniment for treating psoriasis and preparation method thereof | |
CN105250712B (en) | A kind of Chinese medicine composition for treating bedsore | |
CN101073648A (en) | Method for treating senile constipation | |
CN103585334B (en) | Compound diaper ointment | |
CN107260781A (en) | It is a kind of to treat pharmaceutical composition of gout and preparation method thereof | |
CN103705681B (en) | A kind of Chinese herbs paste for treating cervical spondylopathy | |
CN102920825B (en) | Tissue regeneration promoting strengthening powder | |
CN103893328B (en) | Traditional Chinese medicine pill used for treating hyperplasia of mammary glands | |
CN106038875A (en) | Traditional Chinese medicine plaster for treating cervical spondylosis and preparation method thereof | |
CN109010549A (en) | Synthetism expelling wind and activating blood flow pain relieving ointment and preparation method thereof | |
CN104337913A (en) | External Chinese medicinal composition for treating pressure sore | |
CN105477095A (en) | External traditional Chinese medicine ointment for recovery from burns and scalds | |
CN103933389B (en) | Traditional Chinese medicine composition for treating ovarian cyst | |
CN104013880B (en) | It is a kind of to treat Chinese medicine composition of peritonitis and preparation method thereof | |
CN103432320B (en) | A kind of impel open wound and carbuncle skin ulcer swell ulceration healing external powder medicine for removing necrotic tissue and promoting muscle growing | |
CN110478421A (en) | A kind of Chinese materia medica preparation and preparation method thereof for treating goat | |
CN101185696B (en) | Cream shape medicine for treating II or III degree bedsore | |
CN107126451A (en) | It is a kind of to treat external medicine composition of hemorrhoid and preparation method thereof | |
CN101810703A (en) | Chinese medicament for treating burns and scalds | |
CN104984266A (en) | Traditional Chinese medicine composition for treating hyperostosis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120822 |